Ananta Khurana, MD; Aastha Agarwal, MD; Diksha Agrawal, MD; et al.
This randomized clinical trial compares cure rates, treatment durations, safety profiles, and relapse rates of itraconazole, 100, 200, and 400 mg/d, for the treatment of tinea corporis/cruris in adult patients.